Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Just this month, on January 29, 2026, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) issued an important update for patients and prescribers
Taken together, these results demonstrate that C1-27 targets GSTO1 in tumours and shows promising antitumour activity in both cell line xenograft and PDX models of colorectal cancer, without gross systemic toxicities
However, oral formulations may produce different side effect patterns that could affect hydration status differently than injectable versions
These compounds, frequently used to remove heavy metals such as mercury, lead, and arsenic, exhibit high affinity and specificity, enabling effective and safe detoxification in different or complementary clinical situations compared to EDTA
US$ 29.48
US$ 20.93
US$ 29.49
US$ 27.34
US$ 20.72
US$ 22.32
